1. Analyze the impact of anticoagulation transitions in various healthcare settings, such as ambulatory oral anticoagulant use and subsequent inpatient transitions.

2. Formulate a plan to overcome barriers to transitions of care for patients on anticoagulation.

3. Examine common diabetes-related transition of care topics, including changes in inpatient to outpatient diabetes management, and steroid induced hyperglycemia.

4. Examine the inpatient use of outpatient diabetes technologies and implement strategies to minimize or prevent medication and/or technology errors that commonly occur in transitions of care for patients with diabetes.

5. Review legislative changes to opioid use disorder treatment, including DATA 2000 and elimination of requirements.

6. Design a treatment plan for opioid withdrawal and pain management in patients with opioid use disorder, with emphasis on how this affects transitions of care.

1. ​​Characterize potential sources of bias in AI which may perpetuate healthcare disparities.​

2. ​​Describe successful applications of AI in pharmacy education and clinical practice.​

3. ​​Discuss challenges associated with the incorporation of AI into pharmacy research, teaching, and practice.​

4. ​​Recognize how AI can be incorporated across practice settings.

5. ​​List key considerations for the incorporation of AI into pharmacy practice.​

1. Describe the common types of “disrupters” in pharmacy delivery systems.

2. Identify legal and regulatory influences on the shifting environment of community pharmacy practice.

3. Evaluate challenges facing pharmacies from vertically integrated health care mergers.

4. Recognize pros and cons of cost-savings programs to enhance affordable access to medications.

5. Discuss methods to elevate the practice of the pharmacist as healthcare providers.

6. Summarize examples of clinical pharmacy service expansion in community pharmacy.

1. Review the various sources of misinformation including fabricated and manipulated content and their impact on patient care and healthcare outcomes.

2. Review strategies to identify and mitigate misinformation in education, practice, and patient care.

3. Discuss the challenges of information literacy in the age of AI.

4.Review the impact of misinformation on vulnerable populations. 

5. Discuss strategies to identify and counteract misinformation online, including social media and optimize AI use.

1. Describe the current indications for long-acting antiretroviral therapy in people living with HIV.

2. Explain the use of long-acting antiretroviral therapy in special populations.

3. Review investigational long-acting therapies for HIV treatment and cure.

4. Describe the current indications for long-acting antiretroviral therapy for HIV prevention.

5. Explain the use of long-acting HIV prevention in special populations.

6. Review investigational long-acting therapies for HIV prevention.

1. Summarize key deficiencies, barriers, and challenges in the implementation of treatments for acute ischemic stroke.

2. Critique the medical literature investigating the use of emerging treatment options in the management of acute ischemic stroke.

3. When given a patient case, develop a pharmacotherapy plan for treatment of acute ischemic stroke.

4. Develop a personal action plan for best practices associated with pharmacist participation in the care of the patient with acute ischemic stroke.

1. Identify appropriate candidates for deescalation in drug therapy.

2. Examine application of new evidence surrounding duration of pharmacotherapy in comparison to guidelines in various specialties.

3. Design a pharmacotherapy regimen for patients on dual antiplatelet therapy.

4. Design a pharmacotherapy regimen for patients with asthma using single maintenance and reliever therapy (SMART).

5. Design a pharmacotherapy regimen for patients on proton pump inhibitor therapy.

6. Design a pharmacotherapy regimen for patients on psychotropic medications.

1. Outline artificial and augmented intelligence (AI) applications currently available in practice.

2. Evaluate opportunities to improve precision evidence incorporation into guideline development and implementation into clinical practice.

3. Assess barriers and ethical considerations regarding implementation and clinical applications of AI.

4. Describe how AI can help develop national and international practice guidelines.

5. Examine opportunities to utilize AI to implement national and international practice guidelines into clinical practice.

6. Illustrate how future AI applications can impact patient care and guideline development.

2. Design a regimen for an older adult with diabetes considering goals and patient-related variables.

1. Illllustrate one’s strengths-based leadership domain with team-based behaviors.

2. Describe the role of “blind spots” and “barrier labels” in applying CliftonStrengths® to leadership.

3. Discuss the most appropriate settings for application of Goleman’s six leadership styles.

1. Evaluate first-line pharmacotherapy options for treating older adults with tobacco dependence.

2. Compare and contrast monotherapy versus combination pharmacotherapy for the treatment of older adults with tobacco dependence.

3. Design an individualized smoking cessation treatment plan for an older adult patient.

4. Evaluate obstacles encountered by older adults associated with tobacco cessation and recommend solutions.

5. Summarize areas in which a clinical pharmacist can impact the care of older adults with tobacco dependence.

1. Describe diagnosis and classification of Pulmonary Artery Hypertension through WHO groups.

2. Recognize underlying pathophysiologies of pulmonary hypertension.

3. Discuss pulmonary arterial hypertension risk stratification utilizing multi-parameter assessment tools.

4. Summarize updates in pharmacotherapy for pulmonary arterial hypertension.

5. Summarize evidence for advances in pharmacotherapy for pulmonary hypertension from interstitial lung disease.

1. Compare the top 10 take-home messages from the 2023 Atrial Fibrillation (AF) Guidelines to recommendations from the 2014 and 2019 guidelines.

2. Evaluate 2023 AF guideline use in ambulatory care, focusing on the updated staging system's impact on patient management, emphasizing preventive measures and lifestyle modifications.

3. Develop an evidence-based treatment plan using patient-specific factors based on the 2023 AF guidelines, considering patient adherence, lifestyle modifications, and monitoring challenges.

1. Differentiate types of surveys.

2. Explain the steps necessary for instrument design.

3. Critique survey questions and published methods.

4. Review the NEXT steps in survey research following survey development/selection.

1. Compare the spectrum of activity, pharmacokinetics, and pharmacodynamic properties of newly approved antibiotics for the treatment of difficult-to-treat gram-negative bacterial infections in adult and pediatric populations.

1. Describe the role of community-based pharmacists in dispensing and clinical counseling opportunities with advancements in state protocols.

2. Summarize the outcomes associated with increased availability of opioid agonists to target populations.

3. Describe the clinical pharmacotherapy opportunities within nicotine cessation protocols.

4. Summarize the various payment reimbursement mechanisms for nicotine cessation services.

5. Explain how to integrate a community health worker into a community pharmacy setting.

6. Identify successful strategies to address vaccine confidence with targeted populations.

6. Identify clinical scenarios where novel antifungal agents offer efficacy or safety advantages over established treatments.

1. Describe the value of deprescribing within clinical practice.

2. List key medication classes that should be considered for deprescribing. 

3. Develop a plan to optimize medication management through deprescribing based on a patient's goals of care and prognosis.

4. Apply deprescribing communication techniques using the FRAME communication map.

1. Compare currently available pharmacological agents used in the treatment of obesity.  

2. Assess current guidelines in the management of obesity.

3. Evaluate the cardiovascular benefits of obesity pharmacotherapy and bariatric interventions.

4. Review the most commonly employed bariatric interventions and their impact on pharmacotherapy in patients with obesity.

5. Distinguish the roles of the interprofessional healthcare team in obesity management.

6. Examine possible new agents or therapeutic options in the management of obesity.

1. Apply recent literature surrounding targeted therapy options in hormone receptor-positive (HR+), early-stage breast cancer. 

2. Identify characteristics of early-stage HR+ breast cancer patients most likely to benefit from targeted adjuvant therapy. 

3. Analyze literature regarding the integration of oral selective estrogen receptor degraders into current treatment guidelines. 

4. Recommend appropriate treatment strategies for patients who qualify to receive inhibitors of the PI3K/AKT pathway. 

5. Evaluate targeted treatment options beyond endocrine therapy for HR+ metastatic breast cancer. 

1. Identify the needs of mentees at different stages of their career (early-, mid-, and late-stage).

2. Propose the qualities and benefits of a successful mentor/mentee relationship.

3. Formulate strategies to avoid common pitfalls that can hamper mentor/mentor relationship.

4. Design a short-term plan for reenergizing your career path with mentorship.

1. Analyze the evidence behind the role of vitamins in disease state management.

2. Construct a clinical situation in which vitamins are ineffective or can cause harm.

3. Describe the evidence behind select complementary and alternative treatment modalities.

4. Design an evidence-based approach for applying CAM treatment modalities in various practice setting.

5. Summarize the regulatory oversight or lack thereof surrounding alternative therapies and vitamins.

6. Prepare scenarios discussing pertinent clinical information of vitamins and alternative treatment modalities with patients.

1. Discuss complex case situations and the application of relevant guidelines to patient care.

2. Evaluate how evidence is incorporated into guidelines and grading.

3. Formulate individualized patient care plans utilizing recommendations from guidelines.

4. Illustrate the limitations of guidelines when developing a patient care plan.

5. Defend a position regarding the application of a well-conducted, randomized controlled trial to a patient case vs. a relevant guideline.

6. Explore application of guidelines to various practice settings.

1. Review the definitions for the following: immigrant, refugee, migrant.

2. Analyze overseas and domestic guidance recommendations for United States (US) bound refugees.

3. Recommend a complete treatment regimen with a monitoring plan for a refugee with Helicobacter pylori (H. pylori) infection using recent literature and guideline recommendations.

4. Evaluate current guideline recommendations describing the use of medications for latent tuberculosis.

5. Formulate an alternative treatment regimen for commonly encountered intestinal parasites.

1. Assess clinical data evaluating the integration of PARP inhibitors into the treatment of breast, prostate, ovarian, and pancreatic cancers.

2. Identify patients who are appropriate for initiation of PARP inhibitor therapy. 

3. Describe the pathophysiology, incidence, and risk factors of PARP inhibitor-associated secondary myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). 

4. Summarize treatment paradigm changes with the updated classification of MDS and AML. 

5. Design a treatment strategy for patients with MDS or AML with previous PARP inhibitor exposure. 

1. Debate the utility of guideline-directed medical therapy in advanced heart failure.

2. Create an evidence-based therapy plan for a patient with pulmonary arterial hypertension.

3. Evaluate the evidence for rate versus rhythm control strategies in patients with atrial fibrillation.

4. Design an anticoagulation therapy and monitoring plan in the setting of drug-drug interactions.

1. Interpret key factors when caring for a critically ill patient infrequently encountered in an ICU setting.

2. Examine the key pharmacokinetic and pharmacodynamics alterations in critically ill pregnant patients.

3. Construct a therapeutic plan for the management of pregnancy related acute conditions.

4. Compose a treatment plan for management of an autoimmune disorder in a critically ill patient.

5. Evaluate the efficacy and safety of a therapeutic plan designed for treatment of an autoimmune condition.

6. Analyze a critically ill patient with an oncologic emergency for severity of the condition.

7. Formulate an evidence-based pharmacotherapy plan for oncologic emergencies.